Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Closure of Trading Window

 Concord Drugs Ltd has informed BSE that as per the Companys internal Code for Prevention of Insider Trading (as amended w.e.f. May 15, 2015) the trading window for dealing in the securities of the Company is closed for the Companys Directors / Officers and designated employees of the Company from August 04, 2015 and will re-open 48 hours after the publication of the June quarter results to the public in the Board Meeting scheduled to be held on August 14, 2015.
29-07-2015
Bigul

Shareholding Pattern For June 30, 2015

 Concord Drugs Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.
22-07-2015
Bigul

Financial Results & Auditors Report for March 31, 2015 (Standalone) (Audited)

 Concord Drugs Ltd has informed BSE about the Standalone Financial Results & a copy of the Auditors Report for the period ended March 31, 2015.
30-05-2015
Bigul

Code of Conduct of Fair Disclosure

 Concord Drugs Ltd has informed BSE that the Company has, in compliance with the requirements of the Regulation 8 & Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with SEBI circular dated May 11, 2015 the Board of Directors through circular resolution dated May 12, 2015 formulated and adopted the following:1. Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information and...
18-05-2015
Bigul

Closure of Trading Window

 Concord Drugs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2015, to consider the following:1. Audited Financial Results for the quarter and year ended March 31, 2015.2. Audit report for the quarter and year ended March 31, 2015.Further, as per the Companys internal Code for Prevention of Insider Trading (as amended w.e.f. September 01, 2014) the trading window for dealing...
14-05-2015
Bigul

Revised Shareholding Pattern For March 31, 2015

 With reference to earlier announcement regarding Shareholding Pattern For March 31, 2015 dated April 21, 2015.Concord Drugs Ltd has now submitted to BSE a Revised Shareholding Pattern For March 31, 2015.
14-05-2015
Bigul

Shareholding Pattern For March 31, 2015

 Concord Drugs Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.
21-04-2015
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

 Concord Drugs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
01-04-2015
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 V Raja Sekhar Reddy has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
01-04-2015
Bigul

Outcome of Board Meeting

 Concord Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 30, 2015, has considered and approved the following :1. Appointment of Ms. P. Chandra Kala as Woman Director.2. Appointment of Secretarial Auditor for the financial year 2014-15.3. Redesignation of Mr. Koni Reddy as Director & CFO.4. Appointment of Internal Auditor.
31-03-2015
Next Page
Close

Let's Open Free Demat Account